5-[4-cyclobutyl-2-fluoro-3-[[methyl-(propan-2-ylamino)amino]methyl]phenyl]pyrazin-2-amine
C19H26FN5 — CID 139439441
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[4-cyclobutyl-2-fluoro-3-[[methyl-(propan-2-ylamino)amino]methyl]phenyl]pyrazin-2-amine
5-[4-cyclobutyl-2-fluoro-3-[[methyl-(propan-2-ylamino)amino]methyl]phenyl]pyrazin-2-amine (PubChem CID 139439441) has the molecular formula C19H26FN5 and a molecular weight of 343.45 g/mol. Its IUPAC name is 5-[4-cyclobutyl-2-fluoro-3-[[methyl-(propan-2-ylamino)amino]methyl]phenyl]pyrazin-2-amine.
Molecular Properties
| Compound Name | 5-[4-cyclobutyl-2-fluoro-3-[[methyl-(propan-2-ylamino)amino]methyl]phenyl]pyrazin-2-amine |
|---|---|
| PubChem CID | 139439441 |
| Molecular Formula | C19H26FN5 |
| Molecular Weight | 343.45 g/mol |
| Exact Mass | 343.22 |
| IUPAC Name | 5-[4-cyclobutyl-2-fluoro-3-[[methyl-(propan-2-ylamino)amino]methyl]phenyl]pyrazin-2-amine |
| SMILES | CC(C)NN(C)Cc1c(C2CCC2)ccc(-c2cnc(N)cn2)c1F |
| InChI | InChI=1S/C19H26FN5/c1-12(2)24-25(3)11-16-14(13-5-4-6-13)7-8-15(19(16)20)17-9-23-18(21)10-22-17/h7-10,12-13,24H,4-6,11H2,1-3H3,(H2,21,23) |
| InChIKey | IKCBVVAVEIOKHN-UHFFFAOYSA-N |
| XLogP | 3.48 |
| TPSA | 67.07 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 343.45 |
| LogP ≤ 5 | 3.48 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139439441 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.